Biosimilars Program
Immunology, Oncology
Development & CommercialActive (Partnership-led)
Key Facts
Indication
Immunology, Oncology
Phase
Development & Commercial
Status
Active (Partnership-led)
Company
About Aspen Pharmacare
Aspen Pharmacare's mission is to improve patient health globally through high-quality, affordable medicines. The company has achieved its position as a multinational leader through a disciplined strategy of strategic acquisitions, geographic expansion into over 115 countries, and vertical integration across manufacturing and commercial operations. Its core strategy focuses on marketing and manufacturing a broad portfolio of post-patent, branded pharmaceuticals and sterile injectables, leveraging a world-class, regulatory-approved manufacturing footprint to serve both developed and emerging markets.
View full company profileTherapeutic Areas
Other Immunology, Oncology Drugs
| Drug | Company | Phase |
|---|---|---|
| Biosimilar Candidates | Towa Pharmaceutical | Preclinical / Early Development |
| Biosimilars Pipeline | Jubilant Pharmova | Early Development |
| Biosimilars Development | SPIMACO | Exploratory / Early Development |
| Biosimilar Portfolio | Laboratorios Farmaceuticos Rovi | Clinical Development |